Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA328876
Max Phase: Preclinical
Molecular Formula: C42H75N2NaO6S
Molecular Weight: 737.14
Molecule Type: Small molecule
Associated Items:
ID: ALA328876
Max Phase: Preclinical
Molecular Formula: C42H75N2NaO6S
Molecular Weight: 737.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(NC(=O)CCCCCCCCCCCCCCCC)cc1COS(=O)(=O)[O-].[Na+]
Standard InChI: InChI=1S/C42H76N2O6S.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-42(46)44-40-35-34-39(36-38(40)37-50-51(47,48)49)43-41(45)32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h34-36H,3-33,37H2,1-2H3,(H,43,45)(H,44,46)(H,47,48,49);/q;+1/p-1
Standard InChI Key: VINBTMCXJHEWDY-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 737.14 | Molecular Weight (Monoisotopic): 736.5424 | AlogP: 13.02 | #Rotatable Bonds: 36 |
Polar Surface Area: 121.80 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -1.83 | CX Basic pKa: | CX LogP: 12.28 | CX LogD: 11.65 |
Aromatic Rings: 1 | Heavy Atoms: 51 | QED Weighted: 0.05 | Np Likeness Score: -0.21 |
1. Yoshiizumi K, Nakajima F, Dobashi R, Nishimura N, Ikeda S.. (2004) 2,4-Bis(octadecanoylamino)benzenesulfonic acid sodium salt as a novel scavenger receptor inhibitor with low molecular weight., 14 (11): [PMID:15125934] [10.1016/j.bmcl.2004.03.082] |
Source(1):